|
2563
|
AZD3759
|
Potent, orally active, brain-penetrant, EGFR tyrosine kinase inhibitor |
€85.00 |
|
2575
|
C-DIM12
|
Nurr1 activator that stimulates apoptosis in bladder cancer cells |
€85.00 |
|
2574
|
Defactinib
|
Orally available second generation inhibitor of FAK and PYK2 |
€80.00 |
|
2570
|
FG-2216
|
Orally active HIF-PHD inhibitor that increases plasma EPO levels in vivo |
€80.00 |
|
2572
|
GlyH 101
|
Highly potent and selective CFTR inhibitor |
€105.00 |
|
2571
|
GW 2580
|
Orally bioavailable inhibitor of cFMS kinase and CSF1R |
€75.00 |
|
1984
|
GW 5074
|
Brain-permeable inhibitor of c-Raf (in vitro) with activating effects in vivo |
€85.00 |
|
2569
|
JNJ 63533054
|
Potent, brain-penetrant, selective agonist of GPR139 |
€90.00 |
|
2484
|
K6PC-5
|
SphK1 (or SK1) activator that increases sphingosine-1-phosphate production |
€105.00 |
|
2564
|
NSC 59984
|
Activator of p53 that restores WT p53 signaling via p73 activation |
€95.00 |
|
2531
|
SCR7 pyrazine
|
DNA ligase IV mediated inhibitor of NHEJ |
€65.00 |